Serum concentrations of soluble ICAM-1 and VCAM-1 in patients with colorectal cancer. Clinical implications
β Scribed by K. Giannoulis; C. Angouridaki; G. Fountzilas; C. Papapolychroniadis; E. Giannoulis; O. Gamvros
- Publisher
- Springer
- Year
- 2004
- Tongue
- English
- Weight
- 36 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1123-6337
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Adhesion molecules might play a role in tumor progression. We investigated expression of the adhesion molecules ICAM-1, VCAM-1 and ELAM-1 in 24 primary colorectal carcinomas using immuno-histochemistry and Northern blot analysis. Normal colonic tissue from the same patients served as controls. ICAM-
Serum soluble ICAM-1 concentrations were measured in 10 patients with or without chronic graft-vs.-host disease (GVHD) after allogeneic bone marrow transplantation. The serum soluble ICAM-1 levels in the patients with chronic GVHD were significantly higher than that in the patients without chronic G